Stay updated on Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:52:08.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Updated the page revision from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:24:10.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now shows revision v3.4.2, replacing the previous v3.4.1. This is a minor metadata update that does not affect content, functionality, or user interactions.
    Difference
    0.1%
    Check dated 2026-02-12T01:40:03.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A minor revision label was updated from v3.4.0 to v3.4.1; no substantive study details or content were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:30:13.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    UI and copy updates include a glossary toggle, new labeling for 'Last Update Submitted that Met QC Criteria', and a Revision: v3.4.0, along with related FEAR Act data wording adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T19:25:51.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 from the page. This is an administrative update to the version history and does not affect trial data, eligibility criteria, or study details.
    Difference
    0.1%
    Check dated 2026-01-14T03:53:37.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page.